FR2661613A1 - Solution of plant extracts, its preparation and therapeutic composition containing it - Google Patents

Solution of plant extracts, its preparation and therapeutic composition containing it Download PDF

Info

Publication number
FR2661613A1
FR2661613A1 FR9005634A FR9005634A FR2661613A1 FR 2661613 A1 FR2661613 A1 FR 2661613A1 FR 9005634 A FR9005634 A FR 9005634A FR 9005634 A FR9005634 A FR 9005634A FR 2661613 A1 FR2661613 A1 FR 2661613A1
Authority
FR
France
Prior art keywords
leaves
solution
auriculatum
solanum
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9005634A
Other languages
French (fr)
Other versions
FR2661613B1 (en
Inventor
Rakotondramoma Fidele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9005634A priority Critical patent/FR2661613B1/en
Publication of FR2661613A1 publication Critical patent/FR2661613A1/en
Application granted granted Critical
Publication of FR2661613B1 publication Critical patent/FR2661613B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed

Abstract

The invention relates to a solution of plant extracts, to a process for preparing it and to a therapeutic composition containing it. The subject of the invention is an aqueous solution of extracts of Solanum auriculatum leaves and of robusta coffee leaves. The abovementioned solution is obtained by a process that consists in bringing to the boil water into which dried Solanum auriculatum leaves and dried robusta coffee leaves have been introduced, in keeping the suspension boiling for a period of between 15 and 30 min and in filtering to collect the filtrate. The therapeutic composition is useful for the treatment of asthma.

Description

La présente invention concerne une solution d'extraits de plantes, un procédé pour sa préparation, et une composition thérapeutique la contenant. The present invention relates to a solution of plant extracts, a process for its preparation, and a therapeutic composition containing it.

L'asthme est une maladie très répandue et de nombreux médicaments ont été mis au point pour en réduire les effets. Asthma is a very common disease and many drugs have been developed to reduce its effects.

La présente invention a pour but de fournir une composition qui améliore très rapidement l'état des personnes souffrant d'asthme et qui supprime les effets de cette maladie, suppression aboutissant à une guérison de la maladie. The present invention aims to provide a composition which very quickly improves the condition of people suffering from asthma and which suppresses the effects of this disease, suppression leading to a cure of the disease.

La présente invention a pour objet une solution aqueuse d'extraits de feuilles de solanum auriculatum et de feuilles de caféier Robusta. The present invention relates to an aqueous solution of extracts of solanum auriculatum leaves and of Robusta coffee leaves.

Ladite solution est obtenue par un procédé consistant à porter à l'ébullition de l'eau dans laquelle ont été introduites des feuilles séchées de solanum auriculatum et des feuilles séchées de caféier Robusta, à maintenir l'ébullition pendant une durée comprise entre 15 et 30 mn, à filtrer pour recueillir le filtrat. Said solution is obtained by a process consisting in bringing to the boil of water into which have been introduced dried leaves of solanum auriculatum and dried leaves of Robusta coffee tree, in maintaining the boiling for a period of between 15 and 30 min, to be filtered to collect the filtrate.

De préférence, les feuilles séchées sont humidifiées avant d'être introduites dans l'eau. Preferably, the dried leaves are moistened before being introduced into the water.

En outre, il est préférable d'introduire d'abord les feuilles de caféier Robusta, ensuite les feuilles de solanum auriculatum. In addition, it is preferable to introduce the Robusta coffee leaves first, then the solanum auriculatum leaves.

Les proportions des constituants du mélange porté à l'ébullition sont les suivantes
- feuilles séchées de caféier Robusta 5- 6,5 g
- feuilles séchées de solanum auriculatum 20-30 g
- eau 11
L'invention a également pour objet une composition thérapeutique contenant la solution d'extraits de plantes décrite ci-dessus.The proportions of the constituents of the mixture brought to the boil are as follows
- dried Robusta coffee leaves 5- 6.5 g
- dried leaves of solanum auriculatum 20-30 g
- water 11
The subject of the invention is also a therapeutic composition containing the solution of plant extracts described above.

La composition thérapeutique selon l'invention peut être administrée par voie orale, de préférence sous forme d'un sirop. The therapeutic composition according to the invention can be administered orally, preferably in the form of a syrup.

Un sirop est obtenu en introduisant 6 kg de sucre dans 3,75 1 du filtrat ci-dessus, en portant le mélange à ébullition jusqu'à dissolution et obtention d'une densité de 30 à 35 Baumé. A syrup is obtained by introducing 6 kg of sugar into 3.75 l of the above filtrate, bringing the mixture to the boil until dissolution and obtaining a density of 30 to 35 Baumé.

Dans une variante préférée, on ajoute au mélange, lors de la dissolution du sucre, un agent aromatisant qui peut être de la feuille d'olivier, de l'écorce d'orange, du romarin par exemple. Dans ce cas, le sirop obtenu doit être filtré. L'utilisation d'extrait de menthe comme agent aromatisant est à proscrire, l'extrait de menthe jouant le rôle d'inhibiteur à l'égard des propriétés du filtrat. In a preferred variant, a flavoring agent which can be olive leaf, orange peel, rosemary for example, is added to the mixture, when the sugar is dissolved. In this case, the syrup obtained must be filtered. The use of mint extract as a flavoring agent is to be avoided, the mint extract playing the role of inhibitor with regard to the properties of the filtrate.

Le sirop obtenu doit être conservé à une température inférieure à 20"C.  The syrup obtained must be stored at a temperature below 20 "C.

L'activité de la composition selon l'invention a été testée sur un échantillon de 200 personnes souffrant d'asthme. The activity of the composition according to the invention was tested on a sample of 200 people suffering from asthma.

A ces personnes ont été administrés trois fois par jour, 10 ml du sirop décrit ci-dessus. Après une première période de l'ordre de 10 à 20 jours, une personne traitée subit des accès de toux accompagnée d'expectorations de matières visqueuses. Après cette phase d'expectoration, les crises d'asthme ont disparu, mais le traitement doit être continué pour une période allant de 66 à 110 jours. To these people were administered three times a day, 10 ml of the syrup described above. After a first period of the order of 10 to 20 days, a treated person suffers from attacks of cough accompanied by expectoration of viscous materials. After this expectoration phase, the asthma attacks have disappeared, but treatment should be continued for a period ranging from 66 to 110 days.

Le taux de réussite est de 100%.  The success rate is 100%.

Claims (7)

REVENDICATIONS 1. Solution aqueuse d'extraits de feuilles de solanum auriculatum et de feuilles de caféier Robusta. 1. Aqueous solution of solanum auriculatum leaf extracts and Robusta coffee leaves. 2. Procédé d'obtention de la solution selon la revendication 1, caractérisé en ce qu'il consiste à porter à ébullition un mélange constitué par des feuilles séchées de solanum auriculatum, des feuilles séchées de caféier Robusta et d'eau, à maintenir l'ébullition, puis à filtrer le mélange de manière à récupérer le filtrat constituant ladite solution. 2. A method of obtaining the solution according to claim 1, characterized in that it consists in bringing to a boil a mixture consisting of dried leaves of solanum auriculatum, dried leaves of coffee Robusta and water, to maintain l boiling, then filter the mixture so as to recover the filtrate constituting said solution. 3. Procédé selon la revendication 2, caractérisé en ce que la durée de l'ébullition est comprise entre 15 et 30 mn. 3. Method according to claim 2, characterized in that the duration of the boiling is between 15 and 30 min. 4. Procédé selon l'une des revendications 2 ou 3, caractérisé en ce que la proportion des constituants du mélange est la suivante 4. Method according to one of claims 2 or 3, characterized in that the proportion of the constituents of the mixture is as follows - feuilles de solanum auriculatum 20-30 g - solanum auriculatum leaves 20-30 g - feuilles de caféier Robusta 5- 6,5 g - Robusta coffee leaves 5- 6.5 g - eau 11 - water 11 5. Composition thérapeutique caractérisée en ce qu'elle contient la solution aqueuse selon la revendication 1. 5. Therapeutic composition characterized in that it contains the aqueous solution according to claim 1. 6. Composition selon la revendication 5, caractérisée en ce qu'elle se présente sous forme d'un sirop. 6. Composition according to claim 5, characterized in that it is in the form of a syrup. 7. Composition selon la revendication 6, caractérisée en ce que le sirop est obtenu par dissolution de sucre dans la solution aqueuse, suivie d'une ébullition jusqu'à l'obtention d'une densité comprise entre 30 et 35" Baumé, la quantité de sucre étant comprise entre 1,6 kg et 1,7 kg pour 1 litre de solution d'extraits de plantes.  7. Composition according to Claim 6, characterized in that the syrup is obtained by dissolving sugar in the aqueous solution, followed by boiling until a density of between 30 and 35 "Baumé is obtained, the quantity of sugar being between 1.6 kg and 1.7 kg for 1 liter of solution of plant extracts.
FR9005634A 1990-05-04 1990-05-04 SOLUTION OF PLANT EXTRACTS, ITS PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THE SAME. Expired - Lifetime FR2661613B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9005634A FR2661613B1 (en) 1990-05-04 1990-05-04 SOLUTION OF PLANT EXTRACTS, ITS PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THE SAME.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9005634A FR2661613B1 (en) 1990-05-04 1990-05-04 SOLUTION OF PLANT EXTRACTS, ITS PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THE SAME.

Publications (2)

Publication Number Publication Date
FR2661613A1 true FR2661613A1 (en) 1991-11-08
FR2661613B1 FR2661613B1 (en) 1992-08-14

Family

ID=9396329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9005634A Expired - Lifetime FR2661613B1 (en) 1990-05-04 1990-05-04 SOLUTION OF PLANT EXTRACTS, ITS PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THE SAME.

Country Status (1)

Country Link
FR (1) FR2661613B1 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Eléments de la technique relevés: néant *

Also Published As

Publication number Publication date
FR2661613B1 (en) 1992-08-14

Similar Documents

Publication Publication Date Title
EP0147331B1 (en) Cosmetic or pharmaceutical composition on the basis of plant extracts having an effect on the capillary fragility
FR2578421A1 (en) Pharmaceutical compositions useful for treating memory disorders
FR2698791A1 (en) New extracts of cucurbita sp., Process for their preparation and medicines and cosmetics containing them.
FR2896990A1 (en) Composition useful in a topical cosmetic composition for skin e.g. to fight against skin-aging, comprises a dried vine shoot extract and ectoin ingredient
FR2518406A1 (en) NOVEL PROCESS FOR OBTAINING VASO-ACTIVE SUBSTANCES EXTRACTED FROM GINKGO SHEETS
CA2659162A1 (en) Eucalyptus extract, method of preparation and therapeutic uses thereof
FR2811228A1 (en) USE OF OLIGOSACCHARIDES OR PLANT EXTRACTS BY CONTAINING AS A COSMETIC OR DERMATOLOGICAL AGENT, IN PARTICULAR FOR STIMULATING THE PRODUCTION OF BETA-ENDORPHINE IN THE SKIN
CA1170572A (en) Topical pharmaceutical composition with a total extract of hedysarum fructescens willd as a base
FR2675020A1 (en) SOLID PRODUCT CONTAINING PROPOLIS COMPONENTS, PREPARATION AND APPLICATIONS.
CA2325879A1 (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
FR2661613A1 (en) Solution of plant extracts, its preparation and therapeutic composition containing it
EP0342139B1 (en) Use of arginine aspartate for the manufacture of a medicament for treating certain inflictions of the memory
BE1011413A4 (en) Pharmaceutical composition for lowering blood pressure and method of preparation.
CH664284A5 (en) Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]
CA2909750C (en) Liquid or semi-liquid pharmaceutical, dietary or food composition free of bitterness containing an arginine salt
KR20070017452A (en) Method for using Ajoene as alcohol dehydrogenase inhibitor, and Composition for removing hangover including Ajoene and Method for producing the Composition
FR2825236A1 (en) ORAL COMPOSITION COMPRISING AN ALBISSIA MYRIOPHYLLA BARK EXTRACT AND ITS USE FOR SUPPRESSING OR REDUCING TASTE FUNCTION
FR2710266A1 (en) New compositions in cosmetology and dermatology proposed in the treatment of warts
JPH11116493A (en) Oral administrational preparation for inhibiting intercellular adhesion
CH659943A5 (en) ANTISEPTIC PRODUCT AND METHOD FOR MAKING THIS PRODUCT.
CA2740359A1 (en) Cosmetic composition including an acanthus extract, and use of acanthus in a cosmetic hair-care composition
JPH05178716A (en) Azulene derivative
FR2747308A1 (en) Use of azadirachta indica, hydroxycitrate, ceramides and optionally vitamins or caffeine
WO2023046892A1 (en) Aqueous solution based on syzygium aromaticum, and associated preparation method and uses
FR2650502A1 (en) NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse